SBI Life led the private life insurance segment in Q3 with a 68 bps gain in IRP market share.
SBI Life Insurance Company Limited — Q3 FY26
SBI Life delivered a strong Q3 FY26 with new business premium of INR 31,330 crore (+19% YoY) and individual APE growth of 15%.
Financial stats pending filing verification
2-Minute Summary
SBI Life delivered a strong Q3 FY26 with new business premium of INR 31,330 crore (+19% YoY) and individual APE growth of 15%. PAT grew 4% to INR 1,670 crore, impacted by GST and labor law changes (INR 135 crore one-time). VNB margins held at 27.2% (+34bps YoY), within the guided 26-28% range, aided by favorable product mix shift towards protection and par products. The company maintained its private market share leadership at 25.6% in IRP. Management reiterated full-year APE growth guidance of 13-14% and VNB margin guidance of 27-28%. Key risks include persistency pressure in older cohorts (61-month) and potential regulatory changes on commission caps. Overall, disciplined execution and strong distribution momentum support a positive outlook.
SBI लाइफ ने वित्त वर्ष 2026 की तीसरी तिमाही में शानदार प्रदर्शन किया। नए बिजनेस प्रीमियम 31,330 करोड़ रुपये रहा, जो पिछले साल से 19% ज्यादा है। व्यक्तिगत बीमा पॉलिसियों की बिक्री में 15% का इजाफा हुआ। मुनाफा 4% बढ़कर 1,670 करोड़ रुपये हुआ, लेकिन जीएसटी और मजदूरी कानूनों में बदलाव के कारण 135 करोड़ रुपये का एकमुश्त खर्च हुआ। कंपनी का मुनाफा मार्जिन 27.2% रहा, जो उसके लक्ष्य 26-28% के दायरे में है। इसकी वजह सुरक्षा और गारंटीड रिटर्न वाली पॉलिसियों की बिक्री बढ़ना है। बाजार में SBI लाइफ की हिस्सेदारी 25.6% है। कंपनी ने पूरे साल 13-14% बिक्री वृद्धि और 27-28% मार्जिन का अनुमान दोहराया है। पुरानी पॉलिसियों के बंद होने और कमीशन पर नियमों में बदलाव जोखिम हैं। कुल मिलाकर, मजबूत बिक्री और अनुशासन से भविष्य अच्छा दिखता है।
Key Numbers
Value of new business margin improved 34 bps YoY to 27.2% for 9M FY26, driven by product mix.
Individual protection APE grew 21% YoY, with pure protection surging 98% on APE basis.
13th month persistency improved 101 bps to 87.1%, reflecting better policy retention.
What Changed vs Last Quarter
Management guided VNB margin to remain in the 27-28% range for the coming quarter, despite GST impact of ~30-40 bps net of product mix.
Management indicated that FY27 growth will not be lower than the current growth rate, though formal guidance will be provided later.
Management reiterated full-year APE growth guidance of 13-14%, with Q4 expected to be lower in absolute terms but growth rate positive.
Despite GST headwinds, management expects VNB margin to remain in the 26-28% range, with product mix improvements offsetting the impact.
Management targets protection business contribution to exceed 10% of total APE, driven by new products and rider attachments.
61-month persistency declined due to COVID cohort impact; management expects this to be the last affected cohort but remains a watch item.
Analyst raised concerns about potential commission caps; management acknowledged readiness but no specific impact quantified.
Solvency ratio fell to 1.91 (multi-year low) due to strong protection growth and sum assured expansion; dividend payout may pressure further.
The GST reform has created a 1.74% headwind on VNB margins if product mix remains unchanged. Management expects offset via mix improvement, but failure could compress margins.
Aggressive pricing trends in the industry could pressure margins on non-par guaranteed products, despite disciplined repricing.
H1 growth in these channels was muted at 7% individual APE, though September saw a rebound. Sustained recovery is needed to meet full-year guidance.
🤫 Topics management stopped discussing
Mentioned in Q1 FY26, Q2 FY25, Q2 FY26, Q3 FY25, Q4 FY25
H1 growth in these channels was muted at 7% individual APE, though September saw a rebound. Sustained recovery is needed to meet full-year guidance.
Mentioned in Q1 FY25, Q2 FY25, Q2 FY26, Q3 FY25
Management expects full-year individual APE growth in the range of 13-14%, driven by improved traction in bancassurance and agency channels from September onwards.
Mentioned in Q1 FY26, Q3 FY25, Q4 FY25
Management expects individual APE growth in mid-teens, at par or above private industry levels.
Mentioned in Q1 FY26, Q2 FY26
Aggressive pricing trends in the industry could pressure margins on non-par guaranteed products, despite disciplined repricing.
Mentioned in Q2 FY25, Q3 FY25
Increasing share of unit-linked business could pressure VNB margins if not offset by higher-margin products.
Management Guidance
Full-year APE growth of 13-14%
Management reiterated full-year APE growth guidance of 13-14%, with Q4 expected to be lower in absolute terms but growth rate positive.
Management guidance growthVNB margin guidance of 27-28%
Management guided VNB margin to remain in the 27-28% range for the coming quarter, despite GST impact of ~30-40 bps net of product mix.
Management guidance marginsFY27 growth not lower than current run-rate
Management indicated that FY27 growth will not be lower than the current growth rate, though formal guidance will be provided later.
Management guidance growthKey Risks
Persistency pressure in older cohorts
61-month persistency declined due to COVID cohort impact; management expects this to be the last affected cohort but remains a watch item.
medium · management_commentaryRegulatory commission cap uncertainty
Analyst raised concerns about potential commission caps; management acknowledged readiness but no specific impact quantified.
medium · analyst_questionSolvency ratio decline
Solvency ratio fell to 1.91 (multi-year low) due to strong protection growth and sum assured expansion; dividend payout may pressure further.
low · data_observationNotable Quotes
Our assets under management surpassed INR 5 trillion, reflecting sustained customer confidence and long-term value creation driven by disciplined execution.
We continue to stick to our guidance of between 27% and 28% in the coming quarter also.
The impact that we're going to get on the new business on account of GST, the 150 basis points will get offset mostly by the better product mix... and balance remain will be approximately 30-40 basis points at end of this year.
Frequently Asked Questions
What was SBI Life Insurance Company's revenue in Q3 FY26?
SBI Life Insurance Company reported revenue of — in Q3 FY26, representing a — change compared to the same quarter last year.
What guidance did SBI Life Insurance Company management give for FY27?
Full-year APE growth of 13-14%: Management reiterated full-year APE growth guidance of 13-14%, with Q4 expected to be lower in absolute terms but growth rate positive. VNB margin guidance of 27-28%: Management guided VNB margin to remain in the 27-28% range for the coming quarter, despite GST impact of ~30-40 bps net of product mix. FY27 growth not lower than current run-rate: Management indicated that FY27 growth will not be lower than the current growth rate, though formal guidance will be provided later.
What are the key risks for SBI Life Insurance Company in FY27?
Key risks include Persistency pressure in older cohorts — 61-month persistency declined due to COVID cohort impact; management expects this to be the last affected cohort but remains a watch item.; Regulatory commission cap uncertainty — Analyst raised concerns about potential commission caps; management acknowledged readiness but no specific impact quantified.; Solvency ratio decline — Solvency ratio fell to 1.91 (multi-year low) due to strong protection growth and sum assured expansion; dividend payout may pressure further..
Did SBI Life Insurance Company meet its previous quarter's guidance?
Of 2 tracked promises, management 0 met, 0 close, 2 missed.
Where can I read the full SBI Life Insurance Company Q3 FY26 concall transcript?
The full earnings conference call transcript or source release is available on the linked source material. This page provides an AI-generated summary with filing verification status shown on the financial stats.